Market Experts' LIVE Stock Recommendations: Buy Indian Bank, Metropolis Healthcare, Sell Trent

Mahesh Ojha, assistant vice president of research at Hensex Securities recommended a hold on GAIL (India) Ltd. He advised investors to keep a stop loss of Rs 182 when keeping it lower. The analyst remarked that the stock had more technical support than fundamental in the past two to three months.

Rajesh Agarwal, head of research at AUM Capital, suggested a 'hold' call on Samvardhana Motherson International Ltd. He suggested that investors hold the stock for long term. The analyst further noted that Trump Tariffs may introduce volatility on short term.

He suggested keeping a stoploss of Rs 140-145 for short term.

Vaishali Parekh, vice president of Technical Research At Prabhudas Liladhar recommended a 'hold' view for National Aluminium Co. Ltd. with a short term horizon of three months with a stoploss of Rs 165 and a target of Rs 210.

"If the stock sustains, for a one year horizon, it can go towards Rs 270," the analyst said.

Vaishali Parekh, vice president of Technical Research At Prabhudas Liladhar suggested a 'buy for short term' view for Shakti Pumps (India) Ltd. with a stoploss of Rs 830. She identified the next target of resistance at Rs 950.

Reliance Securities Research Head Vikas Jain recommended a sell for the stock. The stop loss is at Rs 9,480. The target price is at Rs 8,500 apiece, which implied a 5.3% downside from Tuesday's close price.

Religare Broking Retail Research Senior Vice President Ravi Singh recommended a Sell. The target price is Rs 5,500, which implied 1.6% downside from Tuesday's close price. The stop loss is at Rs 5,660 apiece.

Religare Broking Retail Research Senior Vice President Ravi Singh recommended a Buy. The target price is Rs 750, and the stop loss is at 715.

Globe Capital Equity & Commodity Research Head and Associate Vice President Gaurav Sharma recommended a buy for the stock. The stock price is Rs 665 apiece. The stop loss is Rs 618 apiece.

Metropolis Healthcare Ltd. got a buy recommendation from The Street Fund Manager & Trading Strategist Kunal Rambhia. The target price for the stock is Rs 1,800 apiece, which implies a 5.3% upside from Tuesday's close price. The stop loss is at Rs 1,690 apiece.

Out of 24 analysts tracking the company, 18 maintain a 'buy' rating, two recommend a 'hold', and four suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 12.5%.

Angel One Technical and Derivatives Research Chief Manager Osho Krishnan suggested a Buy for the stock. The target price for the counter is Rs 212. The stop loss is at Rs 193 apiece.

Motilal Oswal Financial Services Technical Research and Derivatives Research Chandan Taparia suggested a buy for BEML Ltd. The target price is Rs 4,500 apiece. The stop loss is at Rs 4,230 apiece.

Religare Broking Retail Research Senior Vice President Ravi Singh recommended a Buy. The target price for the stock is Rs 1,824 apiece, which implied 1.5% upside from Tuesday's close price. The stop loss for the stock is Rs 1,778.

The Streets Fund Manager & Trading Strategist Kunal Rambhia recommended a buy for the stock with a target price Rs 1,300 apiece. The current target price implied 2.5% upside from Tuesday's close price. The stop loss is at Rs 1,255 apiece.

Out of 29 analysts tracking the company, 13 maintain a 'buy' rating, seven recommend a 'hold,' and nine suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies a downside of 9.4%.

Angel One Technical and Derivative Research Chief Manager Osho Krishnan suggested a buy for Tata Chemicals Ltd. The target price is Rs 940, which implied 3.5% upside from Tuesday's close price. The stop loss is at Rs 875 apiece.

Aditya Birla Fashion and Retail Ltd., Alkem Laboratories, Indegene Ltd., and Tata Technologies Ltd. are in focus because of expected block deals. Total value of block deal for Wednesday is estimated to be at Rs 3,480 crore.

Ashok Leyland Ltd., Garden Reach Shipbuilders Ltd., One 97 Communication Ltd., and Sun Pharmaceutical Industries Ltd. are in focus because of the business related news flow overnight.

Ashok Leyland received an order worth Rs 182 crore. Garden Reach Shipbuilders signed a deal with Norway's Konsberg to build India's first polar research vessel.

Sun Pharmaceutical Industries reported a successful executed a second phase trial of a drug used in treating inflammatory disease. Yes Bank approved raising fund up to Rs 16,000 crore. Paytm's unit incorporated a new subsidiary, Paytm Singapore.